These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
890 related items for PubMed ID: 22707395
1. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K. Hepatology; 2012 Nov; 56(5):1751-9. PubMed ID: 22707395 [Abstract] [Full Text] [Related]
2. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM. Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462 [Abstract] [Full Text] [Related]
4. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Pirvulescu I, Gheorghe L, Csiki I, Becheanu G, Dumbravă M, Fica S, Martin S, Sarbu A, Gheorghe C, Diculescu M, Copăescu C. Chirurgia (Bucur); 2012 Mar; 107(6):772-9. PubMed ID: 23294957 [Abstract] [Full Text] [Related]
5. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. Furuya CK, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB, Alves VA, Carrilho FJ. J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042 [Abstract] [Full Text] [Related]
6. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA. Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1329-32. PubMed ID: 17702661 [Abstract] [Full Text] [Related]
9. Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease. Bedossa P, FLIP Pathology Consortium. Hepatology; 2014 Aug; 60(2):565-75. PubMed ID: 24753132 [Abstract] [Full Text] [Related]
10. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F. Gastroenterology; 2009 Aug; 137(2):532-40. PubMed ID: 19409898 [Abstract] [Full Text] [Related]
11. [Clinical and histological features of non-alcoholic fatty liver disease]. Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG. Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638 [Abstract] [Full Text] [Related]
12. Histologic spectrum of nonalcoholic fatty liver disease in morbidly obese adolescents. Xanthakos S, Miles L, Bucuvalas J, Daniels S, Garcia V, Inge T. Clin Gastroenterol Hepatol; 2006 Feb; 4(2):226-32. PubMed ID: 16469684 [Abstract] [Full Text] [Related]
13. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Dixon JB, Bhathal PS, O'Brien PE. Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735 [Abstract] [Full Text] [Related]
14. A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients. Campos GM, Bambha K, Vittinghoff E, Rabl C, Posselt AM, Ciovica R, Tiwari U, Ferrel L, Pabst M, Bass NM, Merriman RB. Hepatology; 2008 Jun; 47(6):1916-23. PubMed ID: 18433022 [Abstract] [Full Text] [Related]
15. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience. Reha JL, Lee S, Hofmann LJ. Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798 [Abstract] [Full Text] [Related]
16. Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study. Rastogi A, Shasthry SM, Agarwal A, Bihari C, Jain P, Jindal A, Sarin S. APMIS; 2017 Nov; 125(11):962-973. PubMed ID: 29076589 [Abstract] [Full Text] [Related]
17. Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. Francque SM, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, Michielsen P, Van Gaal L. Clin Gastroenterol Hepatol; 2012 Oct; 10(10):1162-8; quiz e87. PubMed ID: 22796457 [Abstract] [Full Text] [Related]
18. A modification of the Brunt system for scoring liver histology of patients with non-alcoholic fatty liver disease. Merat S, Khadem-Sameni F, Nouraie M, Derakhshan MH, Tavangar SM, Mossaffa S, Malekzadeh R, Sotoudeh M. Arch Iran Med; 2010 Jan; 13(1):38-44. PubMed ID: 20039768 [Abstract] [Full Text] [Related]
19. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes. Rodríguez-Hernández H, Gonzalez JL, Márquez-Ramirez MD, Flores-Hernandez M, Rodríguez-Morán M, Guerrero-Romero F. Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941 [Abstract] [Full Text] [Related]
20. Serologic predictors of nonalcoholic steatohepatitis in a population undergoing bariatric surgery. Chisholm J, Seki Y, Toouli J, Stahl J, Collins J, Kow L. Surg Obes Relat Dis; 2012 May; 8(4):416-22. PubMed ID: 21865094 [Abstract] [Full Text] [Related] Page: [Next] [New Search]